Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes

Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes

US Patent 5871997 · Granted Feb 16, 1999

Estimated economic value: $2,437,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method and device for in vivo tissue regeneration on the interior surface of hol2025
Method and device for in vivo bronchus regeneration2024
Methods and compositions for treating complement-associated disorders2023
Method and device for in vivo tissue regeneration on the interior surface of hol2022
Anti-C5A antibodies2022
Method and device for in vivo bronchus regeneration2022
Reagents and methods for detecting PNH type II white blood cells and their ident2021
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of com2020
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of com2020
Anti-C5a antibodies2019
Reagents and methods for detecting PNH type II white blood cells and their ident2018
Methods of producing anti-C5a antibodies2018